Analysts/Institutional Investor Meet/Con. Call Updates

Ref: ADL/SE/2026-27/60 November 4, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348 Dear Sir/Madam, Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Recording of Conference Call In continuation to our letter bearing Ref no. ADL/SE/2026-27/56 dated October 28, 2026 regarding intimation of Investors/ Analyst conference call on the Financial Results of the Company for the Quarter and half year ended September 30, 2026, we would like to inform you that the audio recording of the said call has been uploaded on the Company’s website. This can be accessed via the following link. Link: https://www.aartidrugs.com/reports-fillings-concall-recording The transcript for the said call will be shared with the Stock Exchanges and will also be uploaded on the Company’s website (https://www.aartidrugs.com ) in due course. This is for your information and record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: F12932